Skip to main content
Key Specialties
Anesthesiology Cardiology Dermatology Diabetology Endocrinology Gastroenterology General Medicine Geriatrics Hematology Infectious Diseases Internal Medicine Nephrology Neurology Obstetrics and Gynecology Oncology Pediatrics Psychiatry Radiology Respiratory Medicine Rheumatology Surgery Urology
Congress Coverage
2024 ESMO Congress 2024 ERS Congress 2024 EASD Congress 2024 ESC Congress 2024 EAN Congress 2024 ASCO Annual Meeting 2024 ACC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on modern management of frailty

LIVE: Thursday 17th October 2024, 18:00-19:30 (CEST)

Frailty has a significant impact on health and wellbeing, especially in older adults. Join our experts to understand the factors that contribute to the development of frailty and find out how to manage the condition and reduce the risk of disability, dependency, and mortality.
ADVANCED SEARCH
Log in
Top
Current Reviews in Musculoskeletal Medicine

Open Access 27-09-2024 | Tendinopathy | Review

The Effect of Platelet Dose on Outcomes after Platelet Rich Plasma Injections for Musculoskeletal Conditions: A Systematic Review and Meta-Analysis

Authors: William Berrigan, Frances Tao, Joel Kopcow, Anna L. Park, Isabel Allen, Peggy Tahir, Aakash Reddy, Zachary Bailowitz

Published in: Current Reviews in Musculoskeletal Medicine

Login to get access

Abstract

Purpose of Review

This study aims to systematically review platelet dosage in platelet rich plasma (PRP) injections for common musculoskeletal conditions.

Recent Findings

Notable heterogeneity exists in the literature regarding platelet dosage. Clinical studies indicate that a higher dosage may lead to improved outcomes concerning pain relief, functional improvement, and chondroprotection in knee osteoarthritis (OA). However, the impact of dosing on other musculoskeletal pathologies remains uncertain. Our investigation identifies a potential dose-response relationship between platelet dose and PRP effectiveness for knee OA treatment, pinpointing an optimal threshold of greater than 10 billion platelets for favorable clinical outcomes. Notably, this effect appears more pronounced for functional outcomes than for pain relief. For other conditions, a lower dosage may suffice, although the existing literature lacks clarity on this matter.

Summary

PRP dosage may significantly influence treatmentoutcomes, particularly in knee OA. Further research is warranted to elucidate optimal dosages for varying conditions.
Appendix
Available only for authorised users
Literature
1.
Bacevich BM, Smith RDJ, Reihl AM, Mazzocca AD, Hutchinson ID. Advances with platelet-rich plasma for Bone Healing. Biologics. 2024;18:29–59.PubMedPubMedCentral
2.
Nelson PA, George T, Bowen E, Sheean AJ, Bedi A. An update on Orthobiologics: cautious optimism. Am J Sports Med. 2024;52(1):242–57.CrossRefPubMed
3.
Marx RE. Platelet-rich plasma (PRP): what is PRP and what is not PRP? Implant Dent. 2001;10(4):225–8.CrossRefPubMed
4.
Murray IR, Geeslin AG, Goudie EB, Petrigliano FA, LaPrade RF. Minimum Information for Studies Evaluating Biologics in Orthopaedics (MIBO): platelet-rich plasma and mesenchymal stem cells. J Bone Joint Surg Am. 2017;99(10):809–19.CrossRefPubMed
5.
Southworth TM, Naveen NB, Tauro TM, Leong NL, Cole BJ. The use of platelet-rich plasma in symptomatic knee osteoarthritis. J Knee Surg. 2019;32(1):37–45.CrossRefPubMed
6.
Townsend C, Von Rickenbach KJ, Bailowitz Z, Gellhorn AC. Post-procedure Protocols following platelet-rich plasma injections for Tendinopathy: a systematic review. Pm r. 2020;12(9):904–15.CrossRefPubMed
7.
Everts PA, van Erp A, DeSimone A, Cohen DS, Gardner RD. Platelet Rich plasma in Orthopedic Surgical Medicine. Platelets. 2021;32(2):163–74.CrossRefPubMed
8.
Everts PA, Lana JF, Onishi K, Buford D, Peng J, Mahmood A, et al. Angiogenesis and tissue repair depend on platelet dosing and Bioformulation Strategies following Orthobiological platelet-rich plasma procedures: a narrative review. Biomedicines. 2023;11(7):1922.CrossRefPubMedPubMedCentral
9.
Mathes T, Pieper D. Clarifying the distinction between case series and cohort studies in systematic reviews of comparative studies: potential impact on body of evidence and workload. BMC Med Res Methodol. 2017;17(1):107.CrossRefPubMedPubMedCentral
10.
Lana J, Purita J, Paulus C, Huber SC, Rodrigues BL, Rodrigues AA, et al. Contributions for classification of platelet rich plasma - proposal of a new classification: MARSPILL. Regen Med. 2017;12(5):565–74.CrossRefPubMed
11.
Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The Cochrane collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.CrossRefPubMedPubMedCentral
12.
Montañez-Heredia E, Irízar S, Huertas PJ, Otero E, Del Valle M, Prat I et al. Intra-articular injections of platelet-rich plasma versus hyaluronic acid in the treatment of osteoarthritic knee pain: A randomized clinical trial in the context of the Spanish national health care system. International Journal of Molecular Sciences. 2016;17(7).
13.
Sandhu JS, Sagar S, Sahu S, Raghuvanshi R, Paliwal H, Jain BK. A prospective study of intra- articular injection of platelet Rich plasma (PRP) in knee osteoarthritis. Eur J Mol Clin Med. 2022;9(3):6014–22.
14.
Saqlain L, Hussain SS, Keerio NH, Qureshi MA, Valecha NK, Noor SS. Effect of platelet Rich plasma injection effect on knee osteoarthritis in Elderly: Single Dose versus Double Dose Randomized Clinical Trial.84 – 9.
15.
Silvestre A, Lintingre PF, Pesquer L, Meyer P, Moreau-Durieux MH, Dallaudiére B. Retrospective analysis of responders and impaired patients with knee osteoarthritis treated with two consecutive injections of very pure platelet-rich plasma (PRP). Bioeng (Basel). 2023;10(8).
16.
Zaffagnini S, Andriolo L, Boffa A, Poggi A, Cenacchi A, Busacca M, et al. Microfragmented adipose tissue Versus platelet-rich plasma for the treatment of knee osteoarthritis: a prospective Randomized Controlled Trial at 2-Year follow-up. Am J Sports Med. 2022;50(11):2881–92.CrossRefPubMed
17.
Li M, Huang Z, Wang S, Di Z, Zhang J, Liu H. Intra-articular injections of platelet-rich plasma vs. hyaluronic acid in patients with knee osteoarthritis: preliminary follow-up results at 6-months. Experimental Therapeutic Med. 2021;21(6).
18.
Saita Y, Kobayashi Y, Nishio H, Wakayama T, Fukusato S, Uchino S, et al. Predictors of effectiveness of platelet-rich plasma therapy for knee osteoarthritis: a retrospective cohort study. J Clin Med. 2021;10:19.CrossRef
19.
Sánchez M, Jorquera C, de Dicastillo LL, Fiz N, Knörr J, Beitia M et al. Real-world evidence to assess the effectiveness of platelet-rich plasma in the treatment of knee degenerative pathology: a prospective observational study.
20.
Taniguchi Y, Yoshioka T, Kanamori A, Aoto K, Sugaya H, Yamazaki M. Intra-articular platelet-rich plasma (PRP) injections for treating knee pain associated with osteoarthritis of the knee in the Japanese population: a phase I and IIa clinical trial. Nagoya J Med Sci. 2018;80(1):39–51.PubMedPubMedCentral
21.
Simental-Mendía M, Acosta-Olivo CA, Hernández-Rodríguez AN, Santos-Santos OR, de la Garza-Castro S, Peña-Martínez VM, et al. Intraarticular injection of platelet-rich plasma in knee osteoarthritis: single versus triple application approach. Pilot study. Acta Reumatol Port. 2019;44(2):138–44.PubMed
22.
Akan O, Sarikaya NO, Kocyigit H. Efficacy of platelet-rich plasma administration in patients with severe knee osteoarthritis: can platelet-rich plasma administration delay arthroplasty in this patient population?9473–83.
23.
Bec C, Rousset A, Brandin T, François P, Rabarimeriarijaona S, Dumoulin C et al. A retrospective analysis of characteristic features of responders and impaired patients to a single injection of pure platelet-rich plasma in knee osteoarthritis. J Clin Med. 2021;10(8).
24.
Govila VK, Sanghi S, Singh V, Kumar A. PLATELET-RICH PLASMA (PRP) THERAPY FOR KNEE ARTHRITIS IN A TERTIARY CARE TEACHING HOSPITAL STUDY.72 – 5.
25.
Guillibert C, Charpin C, Raffray M, Benmenni A, Dehaut FX, El Ghobeira G et al. Single injection of high volume of autologous pure PRP provides a significant improvement in knee osteoarthritis: a prospective Routine Care Study. Int J Mol Sci. 2019;20(6).
26.
Subramanyam K, Alguvelly R, Mundargi A, Khanchandani P. Single versus multi-dose intra-articular injection of platelet rich plasma in early stages of osteoarthritis of the knee: a single-blind, randomized, superiority trial. Archives Rheumatol. 2021;36(3):326–34.CrossRef
27.
Tucker JD, Goetz LL, Duncan MB, Gilman JB, Elmore LW, Sell SA, et al. Randomized, Placebo-controlled analysis of the knee synovial environment following platelet-rich plasma treatment for knee osteoarthritis. PM R. 2021;13(7):707–19.CrossRefPubMed
28.
Palco M, Fenga D, Basile GC, Rizzo P, Cavalieri B, Leonetti D et al. Platelet-Rich plasma combined with hyaluronic acid versus leucocyte and platelet-rich plasma in the conservative treatment of knee osteoarthritis. A retrospective study. Medicina (Kaunas. Lithuania). 2021;57(3).
29.
Wang YC, Lee CL, Chen YJ, Tien YC, Lin SY, Chen CH et al. Comparing the efficacy of Intra-articular single platelet-rich plasma(PRP) versus Novel Crosslinked Hyaluronic Acid for early-stage knee osteoarthritis: a prospective, Double-Blind, randomized controlled trial. Med (Kaunas). 2022;58(8).
30.
Nouri F, Babaee M, Peydayesh P, Esmaily H, Raeissadat SA. Comparison between the effects of ultrasound guided intra-articular injections of platelet-rich plasma (PRP), high molecular weight hyaluronic acid, and their combination in hip osteoarthritis: a randomized clinical trial. BMC Musculoskelet Disord. 2022;23(1):856.CrossRefPubMedPubMedCentral
31.
Villanova-López MM, Núñez-Núñez M, Fernández-Prieto D, González-López C, García-Donaire J, Pérez-Pérez A et al. Randomized, double-blind, controlled trial, phase III, to evaluate the use of platelet-rich plasma versus hyaluronic acid in hip coxarthrosis.134-42.
32.
Kirschner JS, Cheng J, Creighton A, Dundas M, Beatty NR, Kingsbury D et al. Efficacy of ultrasound-guided glenohumeral joint injections of platelet-rich plasma versus hyaluronic acid in the treatment of glenohumeral osteoarthritis: a randomized, double-blind controlled trial.S6.
33.
Hasley IB, Bies MM, Hollman JH, Carta KG, Sellon JL, Brault JS. Platelet-Rich Plasma Injection for Thumb Carpometacarpal Joint Osteoarthritis.
34.
Lim W, Park SH, Kim B, Kang SW, Lee JW, Moon YL. Relationship of cytokine levels and clinical effect on platelet-rich plasma-treated lateral epicondylitis.913 – 20.
35.
Gupta PK, Acharya A, Khanna V, Roy S, Khillan K, Sambandam SN. PRP versus steroids in a deadlock for efficacy: long-term stability versus short-term intensity-results from a randomised trial.285 – 94.
36.
Alessio-Mazzola M, Repetto I, Biti B, Trentini R, Formica M, Felli L. Autologous US-guided PRP injection versus US-guided focal extracorporeal shock wave therapy for chronic lateral epicondylitis: a minimum of 2-year follow-up retrospective comparative study.2309499017749986.
37.
Rossi LA, Piuzzi N, Giunta D, Tanoira I, Brandariz R, Pasqualini I et al. Subacromial platelet-rich plasma injections decrease Pain and improve functional outcomes in patients with refractory rotator cuff Tendinopathy.2745-53.
38.
Nejati P, Ghahremaninia A, Naderi F, Gharibzadeh S, Mazaherinezhad A. Treatment of subacromial impingement syndrome: platelet-rich plasma or exercise therapy? A randomized controlled trial.
39.
Cai Y, Sun ZX, Liao BK, Song ZQ, Xiao T, Zhu PF. Sodium Hyaluronate and Platelet-Rich Plasma for Partial-Thickness Rotator Cuff Tears.227 – 33.
40.
Jo CH, Lee SY, Yoon KS, Oh S, Shin S. Allogeneic platelet-rich plasma Versus Corticosteroid Injection for the treatment of Rotator Cuff Disease: a randomized controlled Trial.2129-37.
41.
Hewavithana PB, Wettasinghe MC, Hettiarachchi G, Ratnayaka M, Suraweera H, Wickramasinghe ND et al. Effectiveness of single intra-bursal injection of platelet-rich plasma against corticosteroid under ultrasonography guidance for shoulder impingement syndrome: a randomized clinical trial.
42.
Fitzpatrick J, Bulsara MK, O’Donnell J, McCrory PR, Zheng MH. The effectiveness of platelet-rich plasma injections in gluteal tendinopathy: a Randomized, double-blind controlled trial comparing a single platelet-rich plasma injection with a single corticosteroid Injection.933-9.
43.
Thompson G, Pearson JF. No attributable effects of PRP on greater trochanteric pain syndrome.22–32.
44.
Scott A, Laprade R, Harmon K, Filardo G, Kon E, Villa SD et al. Platelet-rich plasma (PRP) for patellar tendinopathy: a randomized controlled trial of leukocyte-rich PRP or leukocyte-poor PRP vs. saline.S26.
45.
Rodas G, Soler-Rich R, Rius-Tarruella J, Alomar X, Balius R, Orozco L et al. Effect of Autologous Expanded Bone Marrow Mesenchymal Stem Cells or Leukocyte-Poor Platelet-Rich Plasma in Chronic Patellar Tendinopathy (With Gap > 3 mm): Preliminary Outcomes After 6 Months of a Double-Blind, Randomized, Prospective Study.1492 – 504.
46.
Erroi D, Sigona M, Suarez T, Trischitta D, Pavan A, Vulpiani MC et al. Conservative treatment for Insertional Achilles Tendinopathy: platelet-rich plasma and focused shock waves. A retrospective study.98–106.
47.
Usuelli FG, Grassi M, Maccario C, Vigano M, Lanfranchi L, Alfieri Montrasio U, et al. Intratendinous adipose-derived stromal vascular fraction (SVF) injection provides a safe, efficacious treatment for Achilles tendinopathy: results of a randomized controlled clinical trial at a 6-month follow-up. Knee Surg Sports Traumatol Arthrosc. 2018;26(7):2000–10.CrossRefPubMed
48.
Soraganvi P, Nagakiran KV, Raghavendra-Raju RP, Anilkumar D, Wooly S, Basti BD et al. Is platelet-rich plasma injection more effective than steroid injection in the treatment of chronic plantar fasciitis in achieving long-term relief?8–14.
49.
Srivastava V, Vishwas, Rathi R, Ln M, Bl K. PLANTAR FASCIITIS TREATMENT WITH PLATELET-RICH PLASMA INJECTION VERSUS STEROID INJECTION.120-2.
50.
Alessio-Mazzola M, Stambazzi C, Ursino C, Tagliafico A, Trentini R, Formica M. Ultrasound-guided autologous platelet-rich plasma injections Versus Focal Ultrasound-guided extracorporeal shockwave therapy for Plantar fasciitis in athletes and nonathletes: a retrospective comparative study with Minimum 2-Year Follow-Up.417 – 21.
51.
Uzun H, Bitik O, Uzun Ö, Ersoy US, Aktaş E. Platelet-rich plasma versus corticosteroid injections for carpal tunnel syndrome.301-5.
52.
Akpancar S, Gül D. Comparison of platelet rich plasma and prolotherapy in the management of osteochondral lesions of the talus: a retrospective cohort study.5640-7.
53.
Oudelaar BW, Peerbooms JC, Huis in ‘t Veld R, Vochteloo AJH. Concentrations of Blood Components in Commercial Platelet-Rich Plasma Separation Systems: A Review of the Literature. The American Journal of Sports Medicine. 2019;47(2):479 – 87.
54.
Magalon J, Brandin T, Francois P, Degioanni C, De Maria L, Grimaud F, et al. Technical and biological review of authorized medical devices for platelets-rich plasma preparation in the field of regenerative medicine. Platelets. 2021;32(2):200–8.CrossRefPubMed
55.
Mautner K, Malanga GA, Smith J, Shiple B, Ibrahim V, Sampson S, et al. A call for a standard classification system for future biologic research: the rationale for new PRP nomenclature. Pm r. 2015;7(4 Suppl):S53–9.PubMed
56.
Bansal H, Leon J, Pont JL, Wilson DA, Bansal A, Agarwal D, et al. Platelet-rich plasma (PRP) in osteoarthritis (OA) knee: correct dose critical for long term clinical efficacy. Sci Rep. 2021;11(1):3971.CrossRefPubMedPubMedCentral
57.
Patel S, Gahlaut S, Thami T, Chouhan DK, Jain A, Dhillon MS. Comparison of Conventional Dose Versus Superdose platelet-rich plasma for knee osteoarthritis: a prospective, Triple-Blind, randomized clinical trial. Orthop J Sports Med. 2024;12(2):23259671241227863.CrossRefPubMedPubMedCentral
58.
Berrigan WA, Bailowitz Z, Park A, Reddy A, Liu R, Lansdown D. A Greater Platelet Dose May Yield Better Clinical Outcomes for Platelet-Rich Plasma in the Treatment of Knee Osteoarthritis: A Systematic Review. Arthroscopy. 2024.
59.
Ackermann PW, Alim MA, Pejler G, Peterson M. Tendon pain – what are the mechanisms behind it? Scandinavian J Pain. 2023;23(1):14–24.CrossRef
60.
Wasker SVZ, Challoumas D, Weng W, Murrell GAC, Millar NL. Is neurogenic inflammation involved in tendinopathy? A systematic review. BMJ Open Sport Exerc Med. 2023;9(1):e001494.CrossRefPubMedPubMedCentral
61.
Klatte-Schulz F, Thiele K, Scheibel M, Duda GN, Wildemann B. Subacromial Bursa: a neglected tissue is gaining more and more attention in clinical and experimental research. Cells. 2022;11(4).
62.
Morrison LJ, Eby D, Veigas PV, Zhan C, Kiss A, Arcieri V, et al. Implementation trial of the basic life support termination of resuscitation rule: reducing the transport of futile out-of-hospital cardiac arrests. Resuscitation. 2014;85(4):486–91.CrossRefPubMed
63.
Nie LY, Zhao K, Ruan J, Xue J. Effectiveness of Platelet-Rich Plasma in the treatment of knee osteoarthritis: a Meta-analysis of Randomized Controlled clinical trials. Orthop J Sports Med. 2021;9(3):2325967120973284.CrossRefPubMedPubMedCentral
64.
Kim JH, Park YB, Ha CW. Are leukocyte-poor or multiple injections of platelet-rich plasma more effective than hyaluronic acid for knee osteoarthritis? A systematic review and meta-analysis of randomized controlled trials. Archives of Orthopaedic and Trauma Surgery; 2022.
65.
Chen CPC, Chen JL, Hsu CC, Pei YC, Chang WH, Lu HC. Injecting autologous platelet rich plasma solely into the knee joint is not adequate in treating geriatric patients with moderate to severe knee osteoarthritis.1–6.
Metadata
Title
The Effect of Platelet Dose on Outcomes after Platelet Rich Plasma Injections for Musculoskeletal Conditions: A Systematic Review and Meta-Analysis
Authors
William Berrigan
Frances Tao
Joel Kopcow
Anna L. Park
Isabel Allen
Peggy Tahir
Aakash Reddy
Zachary Bailowitz
Publication date
27-09-2024
Publisher
Springer US
Published in
Current Reviews in Musculoskeletal Medicine
Electronic ISSN: 1935-9748
DOI
https://doi.org/10.1007/s12178-024-09922-x